California Department of Public Health

Richmond, California 94804

0 studies enrolling now · 5 studies all time

What they study most

Botulism, HTLV I Associated Myelopathies, HTLV I Associated T Cell Leukemia Lymphoma, HTLV-I Infections, HTLV-II Infections, Human T-lymphotropic Virus 1, Human T-lymphotropic Virus 2, Latent Tuberculosis Infection, Tuberculosis

Studies at this site

• Tolerability and Immunogenicity of a Single 40-ug Dose of rBV A/B for the Production of BabyBIG® — Completed
• Tolerability and Immunogenicity of rBV A/B for the Production of BabyBIG® — Completed
• Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis — Completed
• Safety, Tolerability, and Immunogenicity Study of Investigational Recombinant Botulinum Vaccine A/B (rBV A/B) in Volunteers Previously Immunized With Investigational Pentavalent Botulinum Toxoid — Completed
• Evaluation of the MP Diagnostics HTLV Blot 2.4 — Status unconfirmed